ImmunoVaccine Technologies Inc.

1344 Summer Street Suite 412
Halifax, Nova Scotia B3H 0A8
Canada View Map >>

P: (902) 492-1819
F: (902) 492-0888
Immunovaccine Inc. develops cancer immunotherapies and infectious disease vaccines based on the Company's DepoVax? platform, a patented formulation that provides controlled and prolonged exposure of antigens and adjuvants to the immune system. Immunovaccine has advanced two T cell activation therapies for cancer through Phase I human clinical trial... more

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Contact People at this company

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Contact People at this company

Products & Services

vaccine, therapeutic cancer


Biotechnology, Drug Manufacturing & Research, Business Services

Similar Companies

Wyeth, Medicago Inc., GangaGen Life Sciences Inc., Protox Therapeutics Inc.

Stock Market


SIC Codes

8731, 2834


325412, 541711

Recently updated profiles at this company (25 contacts available)

Pierre Labbe
Chief Financial Officer
Danielle Evans
Executive Assistant
Albert Scardino
Lisa MacDonald
Clinical and Regulatory Affairs Manager
Frederic Ors
Chief Executive Officer
Rita Nigam
Vice President, Clinical Research
Gabriela Rosu
Chief Medical Officer
Marianne Stanford
Director of Research
City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory